Full name
IMPLANTCAST POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
32.50.Z - Manufacture of medical and dental instruments and supplies
46 - Wholesale trade, except of motor vehicles and motorcycles
47 - Retail trade, except motor vehicle retail
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
72.19.Z - Other research and experimental development on natural sciences and engineering
73.20.Z - Market research and public opinion polling
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3,5 | 7,1 | 10,2 | 43,2 |
EBITDA | 4,5 | 9,4 | 10,5 | 11,6 |
Short time liabilities | 18,6 | 20,2 | 28,7 | 42,4 |
Equity capital | 27,9 | 34 | 40,6 | 19,1 |
Operating profit (EBIT) | 4,1 | 8,7 | 10,3 | 18,5 |
Assets | 63,6 | 72,8 | 80 | 9,8 |
Net profit (loss) | 2,4 | 5,9 | 8,1 | 36,4 |
Cash | 0 | 0 | 7,5 | 16 520,3 |
Net income from sale | 52,4 | 57,6 | 69,3 | 20,3 |
Liabilities and provisions for liabilities | 35,7 | 38,8 | 39,4 | 1,7 |
Working assets | 61,7 | 70,3 | 79,4 | 13 |
Depreciation | 0,3 | 0,7 | 0,1 | -77,8 |
% | % | % | p.p. | |
Profitability of capital | 8,5 | 17,4 | 20 | 2,6 |
Equity capital to total assets | 43,9 | 46,8 | 50,7 | 3,9 |
Gross profit margin | 6,6 | 12,4 | 14,8 | 2,4 |
EBITDA Margin | 8,5 | 16,3 | 15,1 | -1,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 129 | 128 | 151 | 23 |
Current financial liquidity indicator | 3.235323667526245 | 3.2913644313812256 | 2.766944646835327 | -0,5 |
Net dept to EBITDA | 4.070321083068848 | 2.010216474533081 | 0.5200132727622986 | -1,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane